BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14(17): 2650-2661 [PMID: 18461650 DOI: 10.3748/wjg.14.2650]
URL: https://www.wjgnet.com/1007-9327/full/v14/i17/2650.htm
(0) (0) (34969) (246)
Number Citing Articles
1
Azadeh Tavakoli, Judith Louise Flanagan. The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics?. Antibiotics 2019; 8(3) doi: 10.3390/antibiotics8030088
2
Eamonn M.M. Quigley. Probiotics in the Management of Functional Bowel Disorders. Gastroenterology Clinics of North America 2012; 41(4) doi: 10.1016/j.gtc.2012.08.005
3
Lynne Vernice McFarland, Tarkan Karatas, Ali Karatas. Strain-Specific and Outcome-Specific Efficacy of Probiotics for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3894914
4
Hafiza Maryam Yasmin, Tahir Zahoor, Ambreen Sagheer, Muhammad Nadeem, Adnan Khaliq, Rabia Iqbal, Samreen Ahsan, Zulfiqar Ahmad. Assessment of antagonistic activity of free and encapsulated Bifidobacterium bifidum against Salmonella. Journal of Food Safety 2018; 38(6) doi: 10.1111/jfs.12546
5
Viola Andresen, Jutta Keller, Christian Pehl, Michael Schemann, Jan Preiss, Peter Layer. Irritable Bowel Syndrome. Deutsches Ärzteblatt international 2011;  doi: 10.3238/arztebl.2011.0751
6
Donald N. Tsynman, Savanna Thor, Joyann A. Kroser. Treatment of Irritable Bowel Syndrome in Women. Gastroenterology Clinics of North America 2011; 40(2) doi: 10.1016/j.gtc.2011.03.012
7
Fergus Shanahan, Eamonn M.M. Quigley. Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies. Gastroenterology 2014; 146(6) doi: 10.1053/j.gastro.2014.01.050
8
G. C. Parkes, J. D. Sanderson, K. Whelan. Treating irritable bowel syndrome with probiotics: the evidence. Proceedings of the Nutrition Society 2010; 69(2) doi: 10.1017/S002966511000011X
9
Richard A. Schatz, Baharak Moshiree. Gastrointestinal and Hepatic Disease in Fibromyalgia. Rheumatic Disease Clinics of North America 2018; 44(1) doi: 10.1016/j.rdc.2017.09.009
10
Marwa M. El-Dalatony, Mostafa El-Sheekh, Xiangkai Li. Gut Remediation of Environmental Pollutants. 2020;  doi: 10.1007/978-981-15-4759-1_6
11
Carmelo Scarpignato, Anna Bertelé, Antonio Tursi. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1) doi: 10.1097/MCG.0000000000000641
12
Mohammad Mehdi Ommati, Huifeng Li, Akram Jamshidzadeh, Fereshteh Khoshghadam, Socorro Retana-Márquez, Yu Lu, Omid Farshad, Mohammad Hasan Nategh Ahmadi, Ahmad Gholami, Reza Heidari. RETRACTED ARTICLE: The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(2) doi: 10.1007/s00210-021-02177-0
13
L. V. McFarland. From Yaks to Yogurt: The History, Development, and Current Use of Probiotics. Clinical Infectious Diseases 2015; 60(suppl 2) doi: 10.1093/cid/civ054
14
Félix Millán Rodríguez, Laia Sabiote Rubio, Irene Girón Nanne, Francisco Sánchez Martín, Esteban Emiliani, Oriol Angerri Feu. The relationship between calcium oxalate lithiasis and chronic proinflammatory intestinal dysbiosis pattern: a prospective study. Urolithiasis 2020; 48(4) doi: 10.1007/s00240-020-01181-y
15
Mitchell L Jones, Christopher J Martoni, Jorge G Ganopolsky, Imran Sulemankhil, Peter Ghali, Satya Prakash. Improvement of gastrointestinal health status in subjects consumingLactobacillus reuteriNCIMB 30242 capsules: apost-hocanalysis of a randomized controlled trial. Expert Opinion on Biological Therapy 2013; 13(12) doi: 10.1517/14712598.2013.833601
16
Ulrike Voß, Anne Lewerenz, Karen Nieber. Sex and Gender Differences in Pharmacology. Handbook of Experimental Pharmacology 2013; 214 doi: 10.1007/978-3-642-30726-3_21
17
Eamonn M. M. Quigley, Fergus Shanahan. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. Advances in Experimental Medicine and Biology 2014; 817 doi: 10.1007/978-1-4939-0897-4_19
18
Bian Tiequn, Chao Guanqun, Zhang Shuo. Therapeutic Effects of Lactobacillus in Treating Irritable Bowel Syndrome: A Meta-analysis. Internal Medicine 2015; 54(3) doi: 10.2169/internalmedicine.54.2710
19
Marika Mikelsaar, Veronica Lazar, Andrew Onderdonk, Gilanfranco Donelli. Do probiotic preparations for humans really have efficacy?. Microbial Ecology in Health and Disease 2011; 22(1) doi: 10.3402/mehd.v22i0.10128
20
Ritu Dahiya, Harpal S. Buttar, Suresh K. Gupta. Handbook of Nutraceuticals and Natural Products. 2022;  doi: 10.1002/9781119746843.ch30
21
Duane Charbonneau, Roger D. Gibb, Eamonn M.M. Quigley. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 2013; 4(3) doi: 10.4161/gmic.24196
22
Elisa Bertazzoni, Gianfranco Donelli, Tore Midtvedt, Jacques Nicoli, Yolanda Sanz. Probiotics and clinical effects: is the number what counts?. Journal of Chemotherapy 2013; 25(4) doi: 10.1179/1973947813Y.0000000078
23
Laiba Arif, Mohammad Moosa Abbasi, Ahmed Asad Raza, Abedin Samadi. From microbiome profiling to precision medicine: diagnostic and therapeutic potential in gastrointestinal disorders: current evidence, challenges, and future directions. Annals of Medicine & Surgery 2026; 88(6) doi: 10.1097/MS9.0000000000005027
24
Luis Fontana, Miriam Bermudez-Brito, Julio Plaza-Diaz, Sergio Muñoz-Quezada, Angel Gil. Sources, isolation, characterisation and evaluation of probiotics. British Journal of Nutrition 2013; 109(S2) doi: 10.1017/S0007114512004011
25
Cheryl Stevenson, Renée Blaauw, Ernst Fredericks, Janicke Visser, Saartjie Roux. Probiotic effect and dietary correlations on faecal microbiota profiles in irritable bowel syndrome. South African Journal of Clinical Nutrition 2021; 34(3) doi: 10.1080/16070658.2019.1697038
26
Perry Hookman, Jamie S Barkin. <italic>Clostridium difficile</italic> associated infection, diarrhea and colitis. World Journal of Gastroenterology 2009; 15(13): 1554-1580 doi: 10.3748/wjg.15.1554
27
Hania Szajewska. Probiotics and Health Claims. 2011;  doi: 10.1002/9781444329384.ch11
28
Eamonn MM Quigley. Prebiotics for irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2009; 3(5) doi: 10.1586/egh.09.46
29
Beth Wallace. Clinical Use of Probiotics in the Pediatric Population. Nutrition in Clinical Practice 2009; 24(1) doi: 10.1177/0884533608329298
30
Heiner Krammer, Markus Bluhm. Probiotika bei Reizdarmsyndrom. Pharmazie in unserer Zeit 2012; 41(2) doi: 10.1002/pauz.201100461
31
Loveleen Kaur Sarao, M. Arora. Probiotics, prebiotics, and microencapsulation: A review. Critical Reviews in Food Science and Nutrition 2017; 57(2) doi: 10.1080/10408398.2014.887055
32
Catherine Ulbricht, Tantri Budiman, Wendy Chao, Shaina Tanguay-Colucci, Julie Conquer, Dawn Costa, Richard Isaac, Joseph Parriott, Amarita Randhawa, Erica Rusie, Jill M. Grimes Serrano, Minney Varghese, Jen Woods, Sara Zhou. Probiotics (Bifidobacterium, Lactobacillus, and Saccharomyces boulardii): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration. Alternative and Complementary Therapies 2011; 17(6) doi: 10.1089/act.2011.17601
33
I. W. Fong. The Role of Microbes in Common Non-Infectious Diseases. 2014;  doi: 10.1007/978-1-4939-1670-2_1
34
Jumana Abuqwider, Mohammad Altamimi, Gianluigi Mauriello. Limosilactobacillus reuteri in Health and Disease. Microorganisms 2022; 10(3) doi: 10.3390/microorganisms10030522
35
Hanneke Bles, Arie Knuistingh Neven. Probiotica bij irritable bowel syndrome. Huisarts en wetenschap 2011; 54(6) doi: 10.1007/s12445-011-0168-y
36
Ji Hye Jeong, Soojin Jang, Bong Jun Jung, Kyung-Soon Jang, Byung-Gee Kim, Dae Kyun Chung, Hangeun Kim. Differential immune-stimulatory effects of LTAs from different lactic acid bacteria via MAPK signaling pathway in RAW 264.7 cells. Immunobiology 2015; 220(4) doi: 10.1016/j.imbio.2014.11.002
37
Charlotte Pratt, Matthew D. Campbell. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Probiotics and Antimicrobial Proteins 2020; 12(3) doi: 10.1007/s12602-019-09609-7
38
Juan José Sebastián Domingo. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología (English Edition) 2017; 40(6) doi: 10.1016/j.gastre.2016.12.001
39
Am&eacute;lie Cayzeele-Decherf, Fanny P&eacute;lerin, S&eacute;bastien Leuillet, Benoit Douillard, B&eacute;atrice Housez, Murielle Cazaubiel, Gunnard K Jacobson, Peter J&uuml;sten, Pierre Desreumaux. <i>Saccharomyces cerevisiae</i> CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World Journal of Gastroenterology 2017; 23(2): 336-344 doi: 10.3748/wjg.v23.i2.336
40
C. Stevenson, R. Blaauw, E. Fredericks, J. Visser, S. Roux. Food avoidance in irritable bowel syndrome leads to a nutrition-deficient diet. South African Journal of Clinical Nutrition 2014; 27(1) doi: 10.1080/16070658.2014.11734481
41
John E. Morley. Probiotics and the Nursing Home: Should We Give Bacteria for Breakfast?. Journal of the American Medical Directors Association 2009; 10(6) doi: 10.1016/j.jamda.2009.04.009
42
Mikihiro Fujiya, Yutaka Kohgo. Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions. Clinical Journal of Gastroenterology 2010; 3(3) doi: 10.1007/s12328-010-0154-0
43
Rodrigo Vázquez-Frias, Alejandra Consuelo-Sánchez, Carlos Patricio Acosta-Rodríguez-Bueno, Andrés Blanco-Montero, Daniel Casas Robles, Vanessa Cohen, Daniel Márquez, Marcos Perez. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Pediatric Drugs 2023; 25(1) doi: 10.1007/s40272-022-00536-9
44
Eamonn M. M. Quigley. Prebiotics and Probiotics. Nutrition in Clinical Practice 2012; 27(2) doi: 10.1177/0884533611423926
45
P. Ducrotté. Ballonnement abdominal : où en est-on ?. Gastroentérologie Clinique et Biologique 2009; 33(10-11) doi: 10.1016/j.gcb.2009.08.004
46
Xing Wang Gao, Mohamed Mubasher, Chong Yu Fang, Cheryl Reifer, Larry E Miller. Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile -Associated Diarrhea Prophylaxis in Adult Patients. American Journal of Gastroenterology 2010; 105(7) doi: 10.1038/ajg.2010.11
47
Nicole Bozzi Cionci, Marta Reggio, Loredana Baffoni, Diana Di Gioia. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16 doi: 10.1007/978-3-031-19564-8_8
48
Ingo B. Autenrieth, Laetitia Bury, Ashley M. Rooney, Matthias Willmann, Maria J.G.T. Vehreschild, Adrian Egli. Paradigms for microbiome analysis in infectious and non-communicable diseases. Trends in Microbiology 2026; 34(5) doi: 10.1016/j.tim.2025.11.016
49
Nicola Principi, Rita Cozzali, Edoardo Farinelli, Andrea Brusaferro, Susanna Esposito. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal of Infection 2018; 76(2) doi: 10.1016/j.jinf.2017.12.013
50
C Stevenson, R Blaauw. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. South African Journal of Clinical Nutrition 2011; 24(2) doi: 10.1080/16070658.2011.11734353
51
Eleonora Giannetti, Marco Maglione, Annalisa Alessandrella, Caterina Strisciuglio, Donatella De Giovanni, Angelo Campanozzi, Erasmo Miele, Annamaria Staiano. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2017; 51(1) doi: 10.1097/MCG.0000000000000528
52
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine. 2022;  doi: 10.2174/9789815051780122010009
53
Ibrahim Elmadfa, Petra Klein, Alexa L. Meyer. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proceedings of the Nutrition Society 2010; 69(3) doi: 10.1017/S0029665110001710
54
Pratima Dibba, Megha Kothari, Irwin Grosman. Nutrition, Weight, and Digestive Health. 2022;  doi: 10.1007/978-3-030-94953-2_11
55
Stephen M. Collins. A role for the gut microbiota in IBS. Nature Reviews Gastroenterology & Hepatology 2014; 11(8) doi: 10.1038/nrgastro.2014.40
56
I. Qureshi, J.R. Endres. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013;  doi: 10.1016/B978-0-12-397154-8.00027-0
57
Oliver Grundmann, Saunjoo L Yoon. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health‐care practitioners. Journal of Gastroenterology and Hepatology 2010; 25(4) doi: 10.1111/j.1440-1746.2009.06120.x
58
Peter Henningsen, Stephan Zipfel, Heribert Sattel, Francis Creed. Management of Functional Somatic Syndromes and Bodily Distress. Psychotherapy and Psychosomatics 2018; 87(1) doi: 10.1159/000484413
59
Emmeline Edwards, D. Lee Alekel, Barbara Stussman. Women and Health. 2013;  doi: 10.1016/B978-0-12-384978-6.00005-4
60
Ashraf MORCOS, Ted DINAN, Eamonn MM QUIGLEY. Irritable bowel syndrome: Role of food in pathogenesis and management. Journal of Digestive Diseases 2009; 10(4) doi: 10.1111/j.1751-2980.2009.00392.x
61
H. Krammer, M. Bluhm, B. Niesler. Reizdarmsyndrom. CME 2012; 9(12) doi: 10.1007/s11298-012-1705-0
62
Hale Akpınar. Probiotics and Prebiotics in Food, Nutrition and Health. 2013;  doi: 10.1201/b15561-16
63
A. N. Suvorov. Microbial personified therapy as an instrument of medical doctor in the future. Russian Journal for Personalized Medicine 2022; 2(1) doi: 10.18705/2782-3806-2022-2-1-51-62
64
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki, Andrew R Miesner. Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 2014; 20(27) doi: 10.3748/wjg.v20.i27.5796
Abstract(0) |  Core Tip(0) |  Full Article(HTML)(0) | Times Cited (1) | Total Visits (0) | Open
65
Marta Caretto, Andrea Giannini, Eleonora Russo, Paolo Mannella, Tommaso Simoncini. Pre-Menopause, Menopause and Beyond. ISGE Series 2018;  doi: 10.1007/978-3-319-63540-8_27
66
Anat Hershko-Moshe, Yaako’v Hasin, Anat Nevo-Shor, Ohad Etzion, Yaron Ilan, Soe Thiha Maung. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance. GastroHep 2022; 2022 doi: 10.1155/2022/1192547
67
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2023;  doi: 10.1007/978-3-031-14744-9_52
68
Silvia Salvatore, Yvan Vandenplas. Bioactive Foods in Promoting Health. 2010;  doi: 10.1016/B978-0-12-374938-3.00013-X
69
Maneesh Dave, Peter D. Higgins, Sumit Middha, Kevin P. Rioux. The human gut microbiome: current knowledge, challenges, and future directions. Translational Research 2012; 160(4) doi: 10.1016/j.trsl.2012.05.003
70
Naire Sansotta, Diego G. Peroni, Simone Romano, Anna Rugiano, Pierluigi Vuilleumier, Giuseppe Baviera. The good bugs: the use of probiotics in pediatrics. Current Opinion in Pediatrics 2019; 31(5) doi: 10.1097/MOP.0000000000000808
71
Mary Ellen Sanders, Maria L. Marco. Food Formats for Effective Delivery of Probiotics. Annual Review of Food Science and Technology 2010; 1(1) doi: 10.1146/annurev.food.080708.100743
72
Motoyori Kanazawa, Shin Fukudo. Relationship between infectious gastroenteritis and irritable bowel syndrome. Clinical Journal of Gastroenterology 2014; 7(1) doi: 10.1007/s12328-013-0444-4
73
Robin Spiller, Fanny Pélerin, Amélie Cayzeele Decherf, Corinne Maudet, Béatrice Housez, Murielle Cazaubiel, Peter Jüsten. Randomized double blind placebo-controlled trial ofSaccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterology Journal 2016; 4(3) doi: 10.1177/2050640615602571
74
Khushi Modi, Sakshi Gohil, Tabassum Khan, Renitta Jobby, Pamela Jha. The Gut Microbiome in Precision Medicine. 2026;  doi: 10.1016/B978-0-443-40483-2.00042-X
75
Xiangping Wang, Yikuan Feng, Jiansheng Li, Zibin Tian, Dong Wei, Lingzhi Qi, Lifeng Fang, Kaichun Wu. Routine clinical administration of 4-week alverine citrate and simeticone combination relief global IBS symptoms. Open Journal of Gastroenterology 2014; 4(01) doi: 10.4236/ojgas.2014.41006
76
Jiayue Gu, Ke Song, Yixuan Fan, Yao Dong, Limin Qian, Zhonghui Gai. Safety evaluation of Bifidobacterium animalis subsp. lactis BLa80 under in vitro, and in vivo conditions. Microbial Pathogenesis 2024; 194 doi: 10.1016/j.micpath.2024.106809
77
Marina L. Ritchie, Tamara N. Romanuk, Markus M. Heimesaat. A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS ONE 2012; 7(4) doi: 10.1371/journal.pone.0034938
78
Gerard E. Mullin, Sue J. Shepherd, Bani Chander Roland, Carol Ireton‐Jones, Laura E. Matarese. Irritable Bowel Syndrome. Journal of Parenteral and Enteral Nutrition 2014; 38(7) doi: 10.1177/0148607114545329
79
Dirk Haller, Jean-Michel Antoine, Stig Bengmark, Paul Enck, Ger T. Rijkers, Irene Lenoir-Wijnkoop. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3. The Journal of Nutrition 2010; 140(3) doi: 10.3945/jn.109.113746
80
Huan Wang, Jing Gong, Wenfeng Wang, Yanqin Long, Xiaochao Fu, Yu Fu, Wei Qian, Xiaohua Hou, Michael Koval. Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model?. PLoS ONE 2014; 9(3) doi: 10.1371/journal.pone.0090153
81
Paul J. Kennedy, Gerard Clarke, Eamonn M.M. Quigley, John A. Groeger, Timothy G. Dinan, John F. Cryan. Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome. Neuroscience & Biobehavioral Reviews 2012; 36(1) doi: 10.1016/j.neubiorev.2011.07.001
82
Christina L. Ohland, Wallace K. MacNaughton. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 298(6) doi: 10.1152/ajpgi.00243.2009
83
Marguerite Klein, Mary Ellen Sanders, Tri Duong, Howard A. Young. Probiotics: From Bench to Market. Annals of the New York Academy of Sciences 2010; 1212(s1) doi: 10.1111/j.1749-6632.2010.05839.x
84
Silvia Pisaneschi, Giulia Palla, Stefania Spina, Guja Bernacchi, Elena Cecchi, Silvia Di Bello, Magdalena Montt Guevara, Adrian Campelo, Tommaso Simoncini. Frontiers in Gynecological Endocrinology. ISGE Series 2014;  doi: 10.1007/978-3-319-03494-2_21
85
Magnus Halland, Nicholas J. Talley. New treatments for IBS. Nature Reviews Gastroenterology & Hepatology 2013; 10(1) doi: 10.1038/nrgastro.2012.207
86
C. H. Choi, J. G. Kwon, S. K. Kim, S.‐J. Myung, K. S. Park, C.‐I. Sohn, P.‐L. Rhee, K. J. Lee, O. Y. Lee, H.‐K. Jung, S. R. Jee, Y. T. Jeen, M.‐G. Choi, S. C. Choi, K. C. Huh, H. Park. Efficacy of combination therapy with probiotics and mosapride in patients withIBSwithout diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial. Neurogastroenterology & Motility 2015; 27(5) doi: 10.1111/nmo.12544
87
Silvia Belloni, Cristina Arrigoni, Arianna Magon, Chiara Giacon, Maria Helena Ceruso, Marco Alfredo Arcidiacono, Gianluca Conte, Rosario Caruso. Symptomatologic outcomes of gut microbiota modifiers (probiotics, prebiotics and synbiotics) in cancer care: A scoping review of randomized controlled trials. Critical Reviews in Oncology/Hematology 2025; 212 doi: 10.1016/j.critrevonc.2025.104779
88
Lynne V. McFarland. Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity. Digestive Diseases and Sciences 2021; 66(3) doi: 10.1007/s10620-020-06244-z
89
Sang-Hoon Lee, Doo-Yeoun Cho, Seok-Hoon Lee, Kyung-Sun Han, Sung-Won Yang, Jin-Ho Kim, Su-Hyun Lee, Soo-Min Kim, Kyu-Nam Kim. A Randomized Clinical Trial of Synbiotics in Irritable Bowel Syndrome: Dose-Dependent Effects on Gastrointestinal Symptoms and Fatigue. Korean Journal of Family Medicine 2019; 40(1) doi: 10.4082/kjfm.17.0064
90
Satish Ramraj, Arul Venkatesan. Nutraceuticals and Functional Foods in Human Health and Disease Prevention. 2015;  doi: 10.1201/b19308-55
91
P. Ducrotté. Post’U FMC-HGE. 2010;  doi: 10.1007/978-2-8178-0097-4_11
92
Gerard E. Mullin. Probiotics and Digestive Disease. Nutrition in Clinical Practice 2012; 27(2) doi: 10.1177/0884533612439609
93
A. Horvath, P. Dziechciarz, H. Szajewska. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Alimentary Pharmacology & Therapeutics 2011; 33(12) doi: 10.1111/j.1365-2036.2011.04665.x
94
Abeer Ahmed Rushdy, Eman Zakaria Gomaa. Antimicrobial compounds produced by probiotic Lactobacillus brevis isolated from dairy products. Annals of Microbiology 2013; 63(1) doi: 10.1007/s13213-012-0447-2
95
J. König, R.J. Brummer. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014; 5(3) doi: 10.3920/BM2013.0033
96
Amir Mari, Fadi Abu Baker, Mahmud Mahamid, Wisam Sbeit, Tawfik Khoury. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. Journal of Clinical Medicine 2020; 9(3) doi: 10.3390/jcm9030685
97
Eamonn M. M. Quigley. Probiotics and Irritable Bowel Syndrome. Bioscience and Microflora 2009; 28(4) doi: 10.12938/bifidus.28.119
98
Oleg Jadrešin, Iva Hojsak, Zrinjka Mišak, Alemka Jaklin Kekez, Tena Trbojević, Lana Ivković, Sanja Kolaček. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(6) doi: 10.1097/MPG.0000000000001478
99
Yehuda Ringel, Tamar Ringel-Kulka. The Rationale and Clinical Effectiveness of Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2011; 45 doi: 10.1097/MCG.0b013e31822d32d3
100
Frederick Odun-Ayo, Lalini Reddy. Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics. Gastroenterology Insights 2022; 13(1) doi: 10.3390/gastroent13010006
101
Michael Camilleri, Emeran A. Mayer. Developing Irritable Bowel Syndrome Guidelines Through Meta-analyses: Does the Emperor Really Have New Clothes?. Gastroenterology 2009; 137(3) doi: 10.1053/j.gastro.2009.07.030
102
L.V. McFarland. The Microbiota in Gastrointestinal Pathophysiology. 2017;  doi: 10.1016/B978-0-12-804024-9.00018-5
103
Charles M.A.P. Franz, Melanie Huch, Hikmate Abriouel, Wilhelm Holzapfel, Antonio Gálvez. Enterococci as probiotics and their implications in food safety. International Journal of Food Microbiology 2011; 151(2) doi: 10.1016/j.ijfoodmicro.2011.08.014
104
Alenka Šmid, Luka Strniša, Katarina Bajc, Dunja Vujić-Podlipec, Bojana Bogovič Matijašić, Irena Rogelj. Randomized clinical trial: The effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults. Journal of Functional Foods 2016; 24 doi: 10.1016/j.jff.2016.04.031
105
N. Saad, C. Delattre, M. Urdaci, J.M. Schmitter, P. Bressollier. An overview of the last advances in probiotic and prebiotic field. LWT - Food Science and Technology 2013; 50(1) doi: 10.1016/j.lwt.2012.05.014
106
Suma S Magge, Jacqueline L Wolf. Complementary and Alternative Medicine and Mind–Body Therapies for Treatment of Irritable Bowel Syndrome in Women. Women's Health 2013; 9(6) doi: 10.2217/WHE.13.57
107
Larysa Hun. Original Research:Bacillus coagulansSignificantly Improved Abdominal Pain and Bloating in Patients with IBS. Postgraduate Medicine 2009; 121(2) doi: 10.3810/pgm.2009.03.1984
108
Verena Grimm, Christian U. Riedel. Microbiota of the Human Body. Advances in Experimental Medicine and Biology 2016; 902 doi: 10.1007/978-3-319-31248-4_8
109
Akira Andoh, Takehide Fujimoto, Kenichiro Takahashi. Association between the Gut Microbiota and Intestinal Disorders. Nihon Naika Gakkai Zasshi 2013; 102(11) doi: 10.2169/naika.102.2983
110
M. Lunder. Dietary Supplements. 2015;  doi: 10.1533/9781782420811.3.171
111
Lynne V McFarland. State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. World Journal of Gastroenterology 2008; 14(17): 2625-2629 doi: 10.3748/wjg.14.2625
112
William D. Heizer, Susannah Southern, Susan McGovern. The Role of Diet in Symptoms of Irritable Bowel Syndrome in Adults: A Narrative Review. Journal of the American Dietetic Association 2009; 109(7) doi: 10.1016/j.jada.2009.04.012
113
W. Allan Walker, Kasey Heintz. Protective Nutrients. Nutrition Today 2012; 47(3) doi: 10.1097/NT.0b013e318257b85c
114
Oscar Brunser, Javier Bravo, Martin Gotteland. Probiotics and Prebiotics in Food, Nutrition and Health. 2013;  doi: 10.1201/b15561-24
115
Aaron J. Michelfelder, Kit C. Lee, Eva M. Bading. Integrative Medicine and Gastrointestinal Disease. Primary Care: Clinics in Office Practice 2010; 37(2) doi: 10.1016/j.pop.2010.02.003
116
G. Sisson, S. Ayis, R. A. Sherwood, I. Bjarnason. Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study. Alimentary Pharmacology & Therapeutics 2014; 40(1) doi: 10.1111/apt.12787
117
Ji-Seon Ahn, Yu-Jin Choi, Han-Byeol Kim, Hea-Jong Chung, Seong-Tshool Hong. Identification of the Intestinal Microbes Associated with Locomotion. International Journal of Molecular Sciences 2023; 24(14) doi: 10.3390/ijms241411392
118
Dirk Haller, Gabriele Hörmannsperger. Biofunktionalität der Lebensmittelinhaltsstoffe. Springer-Lehrbuch 2013;  doi: 10.1007/978-3-642-29374-0_6
119
D. I. Trukhan, V. V. Goloshubina, D. S. Ivanova. Actual issues of diagnosis and treatment of irritable bowel syndrome. Medical Council 2019; (21) doi: 10.21518/2079-701X-2018-21-110-116
120
Tahreem Riaz, Muhammad Waheed Iqbal, Muhammad Saeed, Iqra Yasmin, Hinawi A. M. Hassanin, Shahid Mahmood, Abdur Rehman. In vitro survival of Bifidobacterium bifidum microencapsulated in zein-coated alginate hydrogel microbeads. Journal of Microencapsulation 2019; 36(2) doi: 10.1080/02652048.2019.1618403
121
Gareth C. Parkes. Bioactive Foods in Promoting Health. 2010;  doi: 10.1016/B978-0-12-374938-3.00030-X
122
Bang-Mao Wang, Jia Gao, Ze-Lan Wang, Yu-Ming Wang, Yi-Xin Gu, Mao-Jun Zhang, Kui Jiang, Yuan-Yuan Liu, Li-Juan Feng, Ya-Nan Cao. Effect of <i>Lactobacillus rhamnosus</i> GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome. World Journal of Gastroenterology 2018; 24(3): 338-350 doi: 10.3748/wjg.v24.i3.338
123
Y. A. McKenzie, J. Thompson, P. Gulia, M. C. E. Lomer. British Dietetic Association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5) doi: 10.1111/jhn.12386
124
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017; 82(2) doi: 10.1016/j.rgmxen.2017.03.003
125
Paul Enck, Florian Junne, Sibylle Klosterhalfen, Stephan Zipfel, Ute Martens. Therapy options in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2010;  doi: 10.1097/MEG.0b013e3283405a17
126
Kevin Whelan, Eamonn M.M. Quigley. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Current Opinion in Gastroenterology 2013; 29(2) doi: 10.1097/MOG.0b013e32835d7bba
127
Elizabeth J. Videlock, Lin Chang. Yamada' s Textbook of Gastroenterology. 2015;  doi: 10.1002/9781118512074.ch75
128
S. Liptay, S. Burdach. Probiotika bei Kindern und Jugendlichen mit Darmerkrankung. Monatsschrift Kinderheilkunde 2008; 156(11) doi: 10.1007/s00112-008-1831-7
129
Hamed Ebrahimzadeh Leylabadlo, Fatemah Sadeghpour Heravi, Elghar Soltani, Amin Abbasi, Hossein Samadi Kafil, Mahdi Parsaei, Sarvin Sanaie, Zainab Ahmadian, Reza Ghotaslou. The role of gut microbiota in the treatment of irritable bowel syndrome. Reviews in Medical Microbiology 2022; 33(1) doi: 10.1097/MRM.0000000000000284
130
Magnus Simrén. Review: Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?. Therapeutic Advances in Gastroenterology 2009; 2(4_suppl) doi: 10.1177/1756283X09337569
131
Reizdarmsyndrom wird immer besser verstanden. MMW - Fortschritte der Medizin 2014; 156(19) doi: 10.1007/s15006-014-3643-0
132
H. Krammer, M. Bluhm, B. Niesler. Reizdarmsyndrom. coloproctology 2012; 34(2) doi: 10.1007/s00053-011-0218-8
133
A.R. Bhat, V.U. Irorere, T. Bartlett, D. Hill, G. Kedia, D. Charalampopoulos, S. Nualkaekul, I. Radecka. Improving survival of probiotic bacteria using bacterial poly-γ-glutamic acid. International Journal of Food Microbiology 2015; 196 doi: 10.1016/j.ijfoodmicro.2014.11.031
134
Geoffrey A. Preidis, James Versalovic. Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era. Gastroenterology 2009; 136(6) doi: 10.1053/j.gastro.2009.01.072
135
O. F. Ahmad, A. Akbar. Dietary treatment of irritable bowel syndrome. British Medical Bulletin 2015; 113(1) doi: 10.1093/bmb/ldu039
136
Luise Mølenberg Begtrup, Ove B Schaffalitzky de Muckadell, Jens Kjeldsen, René dePont Christensen, Dorte Ejg Jarbøl. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 2013; 48(10) doi: 10.3109/00365521.2013.825314
137
S. Guandalini, E. Cernat, D. Moscoso. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Beneficial Microbes 2015; 6(2) doi: 10.3920/BM2014.0067
138
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterología. Revista de Gastroenterología de México 2017; 82(2) doi: 10.1016/j.rgmx.2016.08.004
139
Shenghui Zhou, Xiaoli Liu, Xiaoxia Wang, Fenglin Xi, Xiaoke Luo, Liang Yao, Hao Tang. Pharmacological and non-pharmacological treatments for irritable bowel syndrome. Medicine 2019; 98(30) doi: 10.1097/MD.0000000000016446
140
Dirk Haller, Gerald Rimbach, Tilman Grune. Biofunktionalität der Lebensmittelinhaltsstoffe. Springer-Lehrbuch 2013;  doi: 10.1007/978-3-642-29374-0_21
141
Carlo M. Bergamini, Nicoletta Bianchi, Valerio Giaccone, Paolo Catellani, Leonardo Alberghini, Alessandra Stella, Stefano Biffani, Sachithra Kalhari Yaddehige, Tania Bobbo, Cristian Taccioli. Machine Learning Algorithms Highlight tRNA Information Content and Chargaff’s Second Parity Rule Score as Important Features in Discriminating Probiotics from Non-Probiotics. Biology 2022; 11(7) doi: 10.3390/biology11071024
142
Nazar Mazurak, Ellen Broelz, Martin Storr, Paul Enck. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?. Journal of Neurogastroenterology and Motility 2015; 21(4) doi: 10.5056/jnm15071
143
Y. A. McKenzie, R. K. Bowyer, H. Leach, P. Gulia, J. Horobin, N. A. O'Sullivan, C. Pettitt, L. B. Reeves, L. Seamark, M. Williams, J. Thompson, M. C. E. Lomer. British Dietetic Association systematic review and evidence‐based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5) doi: 10.1111/jhn.12385
144
Lynne V. McFarland, Tarkan Karakan, Ali Karatas. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. eClinicalMedicine 2021; 41 doi: 10.1016/j.eclinm.2021.101154
145
Linda V. Thomas, Kaori Suzuki, Jia Zhao. Probiotics: a proactive approach to health. A symposium report. British Journal of Nutrition 2015; 114(S1) doi: 10.1017/S0007114515004043
146
P. Enck, K. Zimmermann, K. Rusch, A. Schwiertz, S. Klosterhalfen, J. S. Frick. The Effects of Maturation on the Colonic Microflora in Infancy and Childhood. Gastroenterology Research and Practice 2009; 2009 doi: 10.1155/2009/752401
147
S. Shukla, A. Shukla, S. Mehboob, S. Guha. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 2011; 33(6) doi: 10.1111/j.1365-2036.2010.04574.x
148
Randal Buddington. Prebiotics and Probiotics Science and Technology. 2009;  doi: 10.1007/978-0-387-79058-9_1
149
Wojciech Marlicz, Diana E Yung, Karolina Skonieczna-Żydecka, Igor Loniewski, Saskia van Hemert, Beata Loniewska, Anastasios Koulaouzidis. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Review of Gastroenterology & Hepatology 2017; 11(10) doi: 10.1080/17474124.2017.1343664
150
Wolfgang Kruis, Sigrun Chrubasik, Stephan Boehm, Christiane Stange, Juergen Schulze. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. International Journal of Colorectal Disease 2012; 27(4) doi: 10.1007/s00384-011-1363-9
151
Stefano Guandalini, Giuseppe Magazzù, Andrea Chiaro, Valeria La Balestra, Giovanni Di Nardo, Sarath Gopalan, A Sibal, Claudio Romano, Roberto Berni Canani, Paolo Lionetti, Mala Setty. VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo‐Controlled, Double‐Blind, Crossover Study. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(1) doi: 10.1097/MPG.0b013e3181ca4d95
152
K. Hod, A. D. Sperber, Y. Ron, M. Boaz, R. Dickman, S. Berliner, Z. Halpern, N. Maharshak, R. Dekel. A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS. Neurogastroenterology & Motility 2017; 29(7) doi: 10.1111/nmo.13037
153
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2017;  doi: 10.1007/978-3-319-49215-5_52
154
Eamonn M.M. Quigley, Fergus Shanahan. Probiotics in Health Care: A Critical Appraisal.  Annual Review of Medicine 2025; 76(1) doi: 10.1146/annurev-med-042423-042315
155
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2013;  doi: 10.1007/978-1-4614-5061-0_46
156
Anna Lyra, Lotta Krogius-Kurikka, Janne Nikkilä, Erja Malinen, Kajsa Kajander, Kyösti Kurikka, Riitta Korpela, Airi Palva. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-110
157
Elvina Parlindungan, Oliver A. H. Jones. Using metabolomics to understand stress responses in Lactic Acid Bacteria and their applications in the food industry. Metabolomics 2023; 19(12) doi: 10.1007/s11306-023-02062-2
158
Jee-Yon Lee, Sang-Hui Chu, Justin Y. Jeon, Mi-Kyung Lee, Ji-Hye Park, Duk-Chul Lee, Ji-Won Lee, Nam-Kyu Kim. Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial. Digestive and Liver Disease 2014; 46(12) doi: 10.1016/j.dld.2014.09.004
159
Helen L. Mitchell, Peter J. Aggett, David P. Richardson, Julian D. Stowell. Food & health forum meeting: evidence-based nutrition. British Journal of Nutrition 2011; 105(2) doi: 10.1017/S0007114510003296
160
H. L. DuPont. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary Pharmacology & Therapeutics 2014; 39(10) doi: 10.1111/apt.12728
161
Aziz Koleilat. Textbook of Clinical Pediatrics. 2012;  doi: 10.1007/978-3-642-02202-9_192
162
Riaz A. Agha, Christian F. Camm, Eric Edison, Dennis P. Orgill. The methodological quality of randomized controlled trials in plastic surgery needs improvement: A systematic review. Journal of Plastic, Reconstructive & Aesthetic Surgery 2013; 66(4) doi: 10.1016/j.bjps.2012.11.005
163
Eamonn M.M. Quigley. Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2015; 49(Supplement 1) doi: 10.1097/MCG.0000000000000348
164
Kevin Whelan. Probiotics and prebiotics in the management of irritable bowel syndrome. Current Opinion in Clinical Nutrition and Metabolic Care 2011; 14(6) doi: 10.1097/MCO.0b013e32834b8082
165
Denis Guyonnet, Armelle Schlumberger, Leila Mhamdi, Stefan Jakob, Olivier Chassany. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. British Journal of Nutrition 2009; 102(11) doi: 10.1017/S0007114509990882
166
Riitta Korpela, Leena Niittynen. Probiotics and Irritable Bowel Syndrome. Microbial Ecology in Health & Disease 2012; 23(0) doi: 10.3402/mehd.v23i0.18573
167
Gerard Mullin. Gastrointestinal and Liver Disease Nutrition Desk Reference. 2011;  doi: 10.1201/b11184-4
168
Joaquim Prado MORAES-FILHO, Eamonn M M QUIGLEY. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review. Arquivos de Gastroenterologia 2015; 52(4) doi: 10.1590/S0004-28032015000400015
169
Uday C Ghoshal, Hyojin Park, Kok‐Ann Gwee. Bugs and irritable bowel syndrome: The good, the bad and the ugly. Journal of Gastroenterology and Hepatology 2010; 25(2) doi: 10.1111/j.1440-1746.2009.06133.x
170
T. Yakabe, E.L. Moore, S. Yokota, H. Sui, Y. Nobuta, M. Fukao, H. Palmer, N. Yajima. Safety assessment of Lactobacillus brevis KB290 as a probiotic strain. Food and Chemical Toxicology 2009; 47(10) doi: 10.1016/j.fct.2009.07.001
171
E. Weichselbaum. Probiotics and health: a review of the evidence. Nutrition Bulletin 2009; 34(4) doi: 10.1111/j.1467-3010.2009.01782.x
172
Sumel Ashique, Tuhin Mukherjee, Satyajit Mohanty, Ashish Garg, Neeraj Mishra, Monika Kaushik, Mithun Bhowmick, Bornika Chattaraj, Sourav Mohanto, Shriyansh Srivastava, Farzad Taghizadeh-Hesary. Blueberries in focus: Exploring the phytochemical potentials and therapeutic applications. Journal of Agriculture and Food Research 2024; 18 doi: 10.1016/j.jafr.2024.101300
173
Paolo Mannella, Giulia Palla, Massimo Bellini, Tommaso Simoncini. The female pelvic floor through midlife and aging. Maturitas 2013; 76(3) doi: 10.1016/j.maturitas.2013.08.008
174
Daniel Villageliú, Mark Lyte, Palok Aich. Dopamine production in Enterococcus faecium: A microbial endocrinology-based mechanism for the selection of probiotics based on neurochemical-producing potential. PLOS ONE 2018; 13(11) doi: 10.1371/journal.pone.0207038
175
Alexander SUVOROV. Gut Microbiota, Probiotics, and Human Health. Bioscience of Microbiota, Food and Health 2013; 32(3) doi: 10.12938/bmfh.32.81
176
Julia-Stefanie Frick, Ingo B. Autenrieth. Between Pathogenicity and Commensalism. Current Topics in Microbiology and Immunology 2012; 358 doi: 10.1007/82_2012_217
177
Fifi M. Reda, Azza Z. Refaie. Purification and characterization of pedioxanthin (carotenoid pigment) produced by Pediococcus pentosaceus N33 strain isolated from pickles . Food Biotechnology 2019; 33(3) doi: 10.1080/08905436.2019.1617166
178
Xue Shang, Fen-Fen E, Kang-Le Guo, Yan-Fei Li, Hong-Lin Zhao, Yan Wang, Nan Chen, Tao Nian, Chao-Qun Yang, Ke-Hu Yang, Xiu-Xia Li. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. Nutrients 2022; 14(12) doi: 10.3390/nu14122482
179
Hao ZHANG, Jing SUN, Qing-yu WANG, Yu-tong HE, Hui-yong GU, Hui-yuan GUO, Qing-bo DING, Jun-si YANG, Fa-zheng REN. Safety Assessment of Lactobacillus salivarius REN, a Probiotic Strain Isolated from Centenarian Feces. Food Science and Technology Research 2013; 19(6) doi: 10.3136/fstr.19.1037
180
M. de Greck, P. Layer, V. Andresen. Schmerztherapie beim Reizdarmsyndrom. Der Schmerz 2014; 28(3) doi: 10.1007/s00482-014-1406-6
181
J.R. Endres, A. Clewell, K.A. Jade, T. Farber, J. Hauswirth, A.G. Schauss. Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 2009; 47(6) doi: 10.1016/j.fct.2009.02.018
182
Emeran A. Mayer, Tor Savidge, Robert J. Shulman. Brain–Gut Microbiome Interactions and Functional Bowel Disorders. Gastroenterology 2014; 146(6) doi: 10.1053/j.gastro.2014.02.037
183
Andrew R Miesner, Erik D Maki, Michelle M Bottenberg, Ginelle A Bryant, Geoffrey C Wall. Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 2014; 20(27): 8796-8806 doi: 10.3748/wjg.v20.i27.8796
184
Asieh Hosseini, Shekoufeh Nikfar, Mohammad Abdollahi. Probiotics use to treat irritable bowel syndrome. Expert Opinion on Biological Therapy 2012; 12(10) doi: 10.1517/14712598.2012.707179
185
Nurzulaikha Abdullah, Yee Cheng Kueh, Garry Kuan, Mung Seong Wong, Fatan Hamamah Yahaya, Nor Aslina Abd Samat, Khairil Khuzaini Zulkifli, Yeong Yeh Lee. Development and validation of the Health Promoting Behaviour for Bloating (HPB-Bloat) scale. PeerJ 2021; 9 doi: 10.7717/peerj.11444
186
Chander Shekhar, Peter J Whorwell. Emerging drugs for irritable bowel syndrome. Expert Opinion on Emerging Drugs 2009; 14(4) doi: 10.1517/14728210903222279
187
K. Preston, R. Krumian, J. Hattner, D. de Montigny, M. Stewart, S. Gaddam. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. Beneficial Microbes 2018; 9(5) doi: 10.3920/BM2017.0105
188
Sonia Michail, Harshavardhan Kenche. Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome. Probiotics and Antimicrobial Proteins 2011; 3(1) doi: 10.1007/s12602-010-9059-y
189
Mark Pimentel, Christopher Chang. Inflammation and Microflora. Gastroenterology Clinics of North America 2011; 40(1) doi: 10.1016/j.gtc.2010.12.010
190
Sadegh Sulaimany, Kajal Farahmandi, Aso Mafakheri. Computational prediction of new therapeutic effects of probiotics. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62796-4
191
Saif Ul Islam. Clinical Uses of Probiotics. Medicine 2016; 95(5) doi: 10.1097/MD.0000000000002658
192
Michael Camilleri, Carlo Di Lorenzo. Brain‐Gut Axis. Journal of Pediatric Gastroenterology and Nutrition 2012; 54(4) doi: 10.1097/MPG.0b013e31823d34c3
193
Magnus Simrén, Giovanni Barbara, Harry J Flint, Brennan M R Spiegel, Robin C Spiller, Stephen Vanner, Elena F Verdu, Peter J Whorwell, Erwin G Zoetendal. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62(1) doi: 10.1136/gutjnl-2012-302167
194
B. Duncan. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013;  doi: 10.1016/B978-0-12-397154-8.00005-1
195
María Torres‑Chávez, Nora Torres‑Carrillo, Ana Moreal‑Lugo, Sandra Garnés‑Rancurello, Selvasankar Murugesan, Itzae Gutiérrez‑Hurtado, Jesús Beltrán‑Ramírez, Elena Sandoval‑Pinto, Norma Torres‑Carrillo. Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review). Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1675
196
Sonia Michail. Probiotics in Pediatric Medicine. 2009;  doi: 10.1007/978-1-60327-289-6_10
197
Stefano Guandalini. Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00023
198
Q. Aziz, J. Doré, A. Emmanuel, F. Guarner, E. M. M. Quigley. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterology & Motility 2013; 25(1) doi: 10.1111/nmo.12046
199
Thanitsara Rittiphairoj, Krit Pongpirul, Noel T. Mueller, Tianjing Li. Probiotics for glycemic control in patients with type 2 diabetes mellitus: protocol for a systematic review. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-1145-y
200
G. Malaguarnera, F. Leggio, M. Vacante, M. Motta, M. Giordano, A. Biondi, F. Basile, S. Mastrojeni, A. Mistretta, Mariano Malaguarnera, M.A. Toscano, M. Salmeri. Probiotics in the gastrointestinal diseases of the elderly. The Journal of nutrition, health and aging 2012; 16(4) doi: 10.1007/s12603-011-0357-1
201
Dorit Vedel Ankersen, Petra Weimers, Mette Bennedsen, Anne Birgitte Haaber, Eva Lund Fjordside, Moritz Emanuel Beber, Christian Lieven, Sanaz Saboori, Nicolai Vad, Terje Rannem, Dorte Marker, Kristine Paridaens, Suzanne Frahm, Lisbeth Jensen, Malte Rosager Hansen, Johan Burisch, Pia Munkholm. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial. Journal of Medical Internet Research 2021; 23(12) doi: 10.2196/30291
202
Ami PATEL, Nihir SHAH. Potentials of probiotics in the treatment of food allergy - a review. Czech Journal of Food Sciences 2014; 32(3) doi: 10.17221/200/2013-CJFS
203
T. Piche. Anomalies pariétales et de la flore au cours du syndrome de l’intestin irritable. Gastroentérologie Clinique et Biologique 2009; 33 doi: 10.1016/S0399-8320(09)71524-6
204
Stefano Guandalini. The Potential for use of Probiotics in Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease. Current Pediatrics Reports 2014; 2(3) doi: 10.1007/s40124-014-0050-z
205
Eamonn M.M. Quigley. Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies. Gastroenterology Clinics of North America 2011; 40(1) doi: 10.1016/j.gtc.2010.12.009
206
Eamonn M. M. Quigley. Probiotics in Gastrointestinal Disorders. Hospital Practice 2010; 38(4) doi: 10.3810/hp.2010.11.349
207
L. Foster, T. Tompkins, W. Dahl. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Beneficial Microbes 2011; 2(4) doi: 10.3920/BM2011.0032
208
Annalisa Passariello, Pascal Agricole, Peter Malfertheiner. A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases. Current Medical Research and Opinion 2014; 30(6) doi: 10.1185/03007995.2014.898138
209
Yi-Heng Chiu, Ying-Chen Lu, Chu-Chyn Ou, Shiao-Lin Lin, Chin-Chi Tsai, Chien-Tsai Huang, Meei-Yn Lin. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Microbiology 2013; 13(1) doi: 10.1186/1471-2180-13-190
210
Dominika Winiarz, Kamila Domańska, Kinga Paluch, Dorota Dorota Skrajnowska. PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO. Prospects in Pharmaceutical Sciences 2017; 15(10) doi: 10.56782/pps.82
211
J.R. Endres, I. Qureshi, T. Farber, J. Hauswirth, G. Hirka, I. Pasics, A.G. Schauss. One-year chronic oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 2011; 49(5) doi: 10.1016/j.fct.2011.02.012
212
Zaigham Abbas, Javed Yakoob, Wasim Jafri, Zubair Ahmad, Zahid Azam, Muhammad W. Usman, Sara Shamim, Muhammad Islam. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2014; 26(6) doi: 10.1097/MEG.0000000000000094
213
Beom Jae Lee, Young-Tae Bak. Irritable Bowel Syndrome, Gut Microbiota and Probiotics. Journal of Neurogastroenterology and Motility 2011; 17(3) doi: 10.5056/jnm.2011.17.3.252
214
Geoffrey A. Preidis, Bruno P. Chumpitazi, Robert J. Shulman. Pediatric Neurogastroenterology. 2017;  doi: 10.1007/978-3-319-43268-7_5
215
Keren Hod, Yehuda Ringel. Probiotics in functional bowel disorders. Best Practice & Research Clinical Gastroenterology 2016; 30(1) doi: 10.1016/j.bpg.2016.01.003
216
K. Hod, Y. Ringel. The Microbiota in Gastrointestinal Pathophysiology. 2017;  doi: 10.1016/B978-0-12-804024-9.00038-0
217
Stephen M Vindigni, Elizabeth K Broussard, Christina M Surawicz. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics forClostridium difficileand beyond. Expert Review of Gastroenterology & Hepatology 2013; 7(7) doi: 10.1586/17474124.2013.832501
218
Nancy Toedter Williams. Probiotics. American Journal of Health-System Pharmacy 2010; 67(6) doi: 10.2146/ajhp090168
219
Hamish Philpott, Sanjay Nandurkar, John Lubel, Peter R Gibson. Alternative investigations for irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2013; 28(1) doi: 10.1111/j.1440-1746.2012.07291.x
220
Julia König, Ignacio Rangel, Robert J. Brummer. The Role of Lactic Acid Bacteria in the Pathophysiology and Treatment of Irritable Bowel Syndrome (IBS). Food and Nutrition Sciences 2013; 4(11) doi: 10.4236/fns.2013.411A005
221
Richard Glickman-Simon, Indranill Basu Ray. Acupuncture, Lactobacillus Traditional Chinese Herbal Medicine, Sanchitongtshu, and Honey. EXPLORE 2012; 8(5) doi: 10.1016/j.explore.2012.06.009
222
Juan José Sebastián Domingo. Revisión del papel de los probióticos en la patología gastrointestinal del adulto. Gastroenterología y Hepatología 2017; 40(6) doi: 10.1016/j.gastrohep.2016.12.003
223
Kajal Farahmandi, Sadegh Sulaimany. Advances in Probiotics for Health and Nutrition. 2024;  doi: 10.5772/intechopen.109717
224
M.J. Hosseini ., R. Ranjbar ., H. Ghasemi ., H.R. Jalalian .. The Prevalence and Antibiotic Resistance of Shigella sp. Recovered from Patients Admitted to Bouali Hospital, Tehran, Iran During 1999-2001. Pakistan Journal of Biological Sciences 2007; 10(16) doi: 10.3923/pjbs.2007.2778.2780
225
Mariana Buranelo Egea, Josemar Gonçalves de Oliveira Filho, Ailton Cesar Lemes. Investigating the Efficacy of Saccharomyces boulardii in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far. International Journal of Molecular Sciences 2023; 24(15) doi: 10.3390/ijms241512015
226
O.Yu. Gubska, A.O. Vanchytskiy, V.I. Tkachenko, V.T. Kiriienko, A.A. Kuzminets, A.V. Panin, O.R. Denesiuk. Irritable bowel syndrome and functional constipation: therapeutic nutrition options for disorders of gut-brain interaction. GASTROENTEROLOGY 2026; 60(2) doi: 10.22141/2308-2097.60.2.2026.723
227
Bo Søndergaard, Johan Olsson, Kajsa Ohlson, Ulla Svensson, Peter Bytzer, Rickard Ekesbo. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial. Scandinavian Journal of Gastroenterology 2011; 46(6) doi: 10.3109/00365521.2011.565066
228
Devaraja Gayathri, Alurappa Ramesha. Gluten‑hydrolyzing probiotics: An emerging therapy for patients with celiac disease (Review). World Academy of Sciences Journal 2020;  doi: 10.3892/wasj.2020.55
229
M. SIMRÉN, L. ÖHMAN, J. OLSSON, U. SVENSSON, K. OHLSON, I. POSSERUD, H. STRID. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double‐blind, controlled study. Alimentary Pharmacology & Therapeutics 2010; 31(2) doi: 10.1111/j.1365-2036.2009.04183.x
230
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Meditsinskiy sovet = Medical Council 2020; (5) doi: 10.21518/2079-701X-2020-5-104-112
231
Rebecca Taylor. What are functional foods and what they can do?. Nursing and Residential Care 2011; 13(2) doi: 10.12968/nrec.2011.13.2.72
232
Natalia Pedersen, Nynne Nyboe Andersen, Zsuzsanna V&eacute;gh, Lisbeth Jensen, Dorit Vedel Ankersen, Maria Felding, Mette Hestetun Simonsen, Johan Burisch, Pia Munkholm. Ehealth: Low FODMAP diet <italic>vs Lactobacillus rhamnosus</italic> GG in irritable bowel syndrome. World Journal of Gastroenterology 2014; 20(43): 16215-16226 doi: 10.3748/wjg.v20.i43.16215
233
Hannah Claire Baker, Dang Ngoc Tran, Linda Valerie Thomas. Health benefits of probiotics for the elderly: a review. Journal of Foodservice 2009; 20(5) doi: 10.1111/j.1748-0159.2009.00147.x
234
Leonilde Bonfrate, Jan Tack, Ignazio Grattagliano, Rosario Cuomo, Piero Portincasa. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scandinavian Journal of Gastroenterology 2013; 48(9) doi: 10.3109/00365521.2013.799220
235
Fredrick Asare, Stine Störsrud, Magnus Simrén. Meditation over Medication for Irritable Bowel Syndrome? On Exercise and Alternative Treatments for Irritable Bowel Syndrome. Current Gastroenterology Reports 2012; 14(4) doi: 10.1007/s11894-012-0268-2
236
Ahmed E. Salem, Rajdeep Singh, Younan K. Ayoub, Ahmed M. Khairy, Gerard E. Mullin. The gut microbiome and irritable bowel syndrome: State of art review. Arab Journal of Gastroenterology 2018; 19(3) doi: 10.1016/j.ajg.2018.02.008
237
Wai-Yee Fung, Huey-Shi Lye, Ting-Jin Lim, Chiu-Yin Kuan, Min-Tze Liong. Probiotics. Microbiology Monographs 2011; 21 doi: 10.1007/978-3-642-20838-6_6
238
Lynne V McFarland. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 2014; 4(8) doi: 10.1136/bmjopen-2014-005047
239
Fariba Tarhani, Alireza Nezami. Role of probiotics in treatment of congenital heart disease and necrotizing enterocolitis. PharmaNutrition 2019; 8 doi: 10.1016/j.phanu.2019.100144
240
Julia König, Robert-Jan Brummer. Pharma-Nutrition. AAPS Advances in the Pharmaceutical Sciences Series 2014; 12 doi: 10.1007/978-3-319-06151-1_4
241
K. Nobutani, D. Sawada, S. Fujiwara, Y. Kuwano, K. Nishida, J. Nakayama, H. Kutsumi, T. Azuma, K. Rokutan. The effects of administration of theLactobacillus gasseristrain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome. Journal of Applied Microbiology 2017; 122(1) doi: 10.1111/jam.13329
242
Theodoros Kelesidis, Charalabos Pothoulakis. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology 2012; 5(2) doi: 10.1177/1756283X11428502
243
Jalal Moludi, Amir Saber, Morteza Arab Zozani, Shima Moradi, Yasaman Azamian, Salimeh Hajiahmadi, Yahya Pasdar, Fardin Moradi. The Efficacy of Probiotics Supplementation on the Quality of Life of Patients with Gastrointestinal Disease: A Systematic Review of Clinical Studies. Preventive Nutrition and Food Science 2024; 29(3) doi: 10.3746/pnf.2024.29.3.237
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.